Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation
- PMID: 16515559
- PMCID: PMC3369267
- DOI: 10.1111/j.1471-4159.2006.03701.x
Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation
Abstract
Dendritic spines are protrusions from the dendritic shaft that host most excitatory synapses in the brain. Although they first emerge during neuronal maturation, dendritic spines remain plastic through adulthood, and recent advances in the molecular mechanisms governing spine morphology have shown them to be exquisitely sensitive to changes in the micro-environment. Among the many factors affecting spine morphology are components and regulators of the extracellular matrix (ECM). Modification of the ECM is critical to the repair of injuries throughout the body, including the CNS. Matrix metalloproteinase (MMP)-7/matrilysin is a key regulator of the ECM during pathogen infection, after nerve crush and in encephalitogenic disorders. We have investigated the effects of MMP-7 on dendritic spines in hippocampal neuron cultures and found that it induces the transformation of mature, short mushroom-shaped spines into long, thin filopodia reminiscent of immature spines. These changes were accompanied by a dramatic redistribution of F-actin from spine heads into thick, rope-like structures in the dendritic shaft. Strikingly, MMP-7 effects on dendritic spines were similar to those of NMDA treatment, and both could be blocked by channel-specific antagonists. These findings are the first direct evidence that MMPs can influence the morphology of mature dendritic spines, and hence synaptic stability.
Figures
Similar articles
-
Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage.J Cell Biol. 2007 Aug 13;178(4):687-700. doi: 10.1083/jcb.200612097. Epub 2007 Aug 6. J Cell Biol. 2007. PMID: 17682049 Free PMC article.
-
Non-Ionotropic NMDA Receptor Signaling Drives Activity-Induced Dendritic Spine Shrinkage.J Neurosci. 2015 Sep 2;35(35):12303-8. doi: 10.1523/JNEUROSCI.4289-14.2015. J Neurosci. 2015. PMID: 26338340 Free PMC article.
-
Activation of N-methyl-D-aspartate receptor induces a shift of drebrin distribution: disappearance from dendritic spines and appearance in dendritic shafts.Mol Cell Neurosci. 2006 Mar;31(3):493-504. doi: 10.1016/j.mcn.2005.11.003. Epub 2005 Dec 20. Mol Cell Neurosci. 2006. PMID: 16368245
-
The role of drebrin in dendritic spines.Mol Cell Neurosci. 2017 Oct;84:85-92. doi: 10.1016/j.mcn.2017.01.004. Epub 2017 Feb 1. Mol Cell Neurosci. 2017. PMID: 28161364 Review.
-
Role of Drebrin in Synaptic Plasticity.Adv Exp Med Biol. 2017;1006:183-201. doi: 10.1007/978-4-431-56550-5_11. Adv Exp Med Biol. 2017. PMID: 28865021 Review.
Cited by
-
Extracellular matrix and synapse formation.Biosci Rep. 2023 Jan 31;43(1):BSR20212411. doi: 10.1042/BSR20212411. Biosci Rep. 2023. PMID: 36503961 Free PMC article.
-
Extracellular Matrix Recycling as a Novel Plasticity Mechanism With a Potential Role in Disease.Front Cell Neurosci. 2022 Mar 31;16:854897. doi: 10.3389/fncel.2022.854897. eCollection 2022. Front Cell Neurosci. 2022. PMID: 35431813 Free PMC article. Review.
-
Targeted therapy of cognitive deficits in fragile X syndrome.Mol Psychiatry. 2022 Jun;27(6):2766-2776. doi: 10.1038/s41380-022-01527-5. Epub 2022 Mar 30. Mol Psychiatry. 2022. PMID: 35354925 Free PMC article.
-
Extracellular Metalloproteinases in the Plasticity of Excitatory and Inhibitory Synapses.Cells. 2021 Aug 11;10(8):2055. doi: 10.3390/cells10082055. Cells. 2021. PMID: 34440823 Free PMC article. Review.
-
Neuropathophysiological Mechanisms and Treatment Strategies for Post-traumatic Epilepsy.Front Mol Neurosci. 2021 Feb 23;14:612073. doi: 10.3389/fnmol.2021.612073. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33708071 Free PMC article. Review.
References
-
- Albensi BC, Janigro D. Traumatic brain injury and its effects on synaptic plasticity. Brain Inj. 2003;17:653–663. - PubMed
-
- Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 1997;23:406–415. - PubMed
-
- Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 2005;8:79–84. - PubMed
-
- Clements JM, Cossins JS, Wells GM, et al. Matrix metalloproteinase expression during experimental allergic encephalomyelitis and effects of a combined metalloproteinase and tumor necrosis factor-α inhibitor. J. Neuroimmunol. 1997;74:85–94. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH067121/MH/NIMH NIH HHS/United States
- 071179/WT_/Wellcome Trust/United Kingdom
- G0400627(71256)/MRC_/Medical Research Council/United Kingdom
- AG21652/AG/NIA NIH HHS/United States
- MH67121/MH/NIMH NIH HHS/United States
- G0600368/MRC_/Medical Research Council/United Kingdom
- G0600368(77987)/MRC_/Medical Research Council/United Kingdom
- G0400627/MRC_/Medical Research Council/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- G0400627(76527)/MRC_/Medical Research Council/United Kingdom
- R01 MH067121-04/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous
